XSWX:MEDX (Switzerland)
Â
Registered Shares
CHF
8.11
+0.080 (+1%)
Jul 10
Business Description
Medmix AG
ISIN : CH1129677105
Share Class Description:
XSWX:MEDX: Registered SharesTotal Employee Number:
2,574Description
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.27 | |||||
Equity-to-Asset | 0.45 | |||||
Debt-to-Equity | 0.78 | |||||
Debt-to-EBITDA | 4.39 | |||||
Interest Coverage | 2.6 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.76 | |||||
Beneish M-Score | -2.6 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -2.4 | |||||
3-Year EBITDA Growth Rate | 2.2 | |||||
3-Year EPS without NRI Growth Rate | -41.2 | |||||
3-Year FCF Growth Rate | 43.2 | |||||
3-Year Book Growth Rate | -5.3 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 64.69 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.41 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 53.27 | |||||
9-Day RSI | 46.54 | |||||
14-Day RSI | 43.46 | |||||
3-1 Month Momentum % | -1.38 | |||||
6-1 Month Momentum % | -25.87 | |||||
12-1 Month Momentum % | -34.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.54 | |||||
Quick Ratio | 1.11 | |||||
Cash Ratio | 0.53 | |||||
Days Inventory | 97.3 | |||||
Days Sales Outstanding | 39.49 | |||||
Days Payable | 55.54 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.23 | |||||
Dividend Payout Ratio | 2.62 | |||||
Forward Dividend Yield % | 1.23 | |||||
5-Year Yield-on-Cost % | 1.23 | |||||
3-Year Average Share Buyback Ratio | 0.2 | |||||
Shareholder Yield % | 7.55 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 36.14 | |||||
Operating Margin % | 6.21 | |||||
Net Margin % | 1.43 | |||||
EBITDA Margin % | 16.79 | |||||
FCF Margin % | 5.96 | |||||
OCF Margin % | 15.13 | |||||
ROE % | 1.49 | |||||
ROA % | 0.67 | |||||
ROIC % | 2.84 | |||||
3-Year ROIIC % | 56.23 | |||||
ROC (Joel Greenblatt) % | 7.12 | |||||
ROCE % | 2.51 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.07 | |||||
Forward PE Ratio | 15.75 | |||||
PE Ratio without NRI | 42.46 | |||||
Price-to-Owner-Earnings | 13.25 | |||||
PS Ratio | 0.76 | |||||
PB Ratio | 0.77 | |||||
Price-to-Tangible-Book | 5.92 | |||||
Price-to-Free-Cash-Flow | 12.71 | |||||
Price-to-Operating-Cash-Flow | 5.01 | |||||
EV-to-EBIT | 29.28 | |||||
EV-to-Forward-EBIT | 11.88 | |||||
EV-to-EBITDA | 7.67 | |||||
EV-to-Forward-EBITDA | 6.84 | |||||
EV-to-Revenue | 1.29 | |||||
EV-to-Forward-Revenue | 1.54 | |||||
EV-to-FCF | 21.6 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 0.56 | |||||
Price-to-Graham-Number | 3.34 | |||||
Earnings Yield (Greenblatt) % | 3.42 | |||||
FCF Yield % | 8.09 | |||||
Forward Rate of Return (Yacktman) % | 5.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medmix AG Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil CHF) | 448 | ||
| EPS (TTM) (CHF) | 0.15 | ||
| Beta | 1.2133 | ||
| 3-Year Sharpe Ratio | -0.71 | ||
| 3-Year Sortino Ratio | -0.96 | ||
| Volatility % | 35.71 | ||
| 14-Day RSI | 43.46 | ||
| 14-Day ATR (CHF) | 0.214985 | ||
| 20-Day SMA (CHF) | 8.1665 | ||
| 12-1 Month Momentum % | -34.08 | ||
| 52-Week Range (CHF) | 7.72 - 13.02 | ||
| Shares Outstanding (Mil) | 40.67 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medmix AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medmix AG Stock Events
| Event | Date | Price (CHF) | ||
|---|---|---|---|---|
| CHF 0.100000 Cash Dividend | 2026-04-20 | 9.12 (+0.88%) | ||
| CHF 0.500000 Cash Dividend | 2025-04-25 | 10.22 (-1.35%) |
Show
Entries
Medmix AG Frequently Asked Questions
What is Medmix AG(XSWX:MEDX)'s stock price today?
The current price of XSWX:MEDX is CHF8.11. The 52 week high of XSWX:MEDX is CHF13.02 and 52 week low is CHF7.72.
When is next earnings date of Medmix AG(XSWX:MEDX)?
The next earnings date of Medmix AG(XSWX:MEDX) is .
Does Medmix AG(XSWX:MEDX) pay dividends? If so, how much?
The Dividend Yield %  of Medmix AG(XSWX:MEDX) is 1.23% (As of Today), Highest Dividend Payout Ratio of Medmix AG(XSWX:MEDX) was 50. The lowest was 0.6. And the median was 4.57. The  Forward Dividend Yield % of Medmix AG(XSWX:MEDX) is 1.23%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medmix AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers